Developer docs
API playgroundTry for free, no card

Search company profiles

LDR Holding

Full company profile

uuid002sl5u

Namestring
LDR Holding
Legal namestring
Highridge Medical
Websiteurl
ldr.com
Company typeenum
Private
Founded yearint
1927
Descriptiontext

LDR Holding, founded in 2004 and headquartered in Austin, Texas, was a medical device company that developed and commercialized systems and instrumentation used in spine treatments and surgeries. Following its 2016 acquisition by Zimmer Biomet and subsequent 2023 divestiture to Linden Capital Partners, the business was rebranded as Highridge Medical and operates as a privately held spine-focused medical device company.

The company maintains a comprehensive spine implant portfolio organized across four categories: cervical solutions, thoracolumbar solutions, enabling technologies, and biologic solutions. Flagship products include Mobi-C (a cervical disc replacement device), ROI-C (cervical disc with integrated plating), Vital (deformity spinal fixation), TrellOss-L and TrellOss-C (porous titanium interbody fusion systems), The Tether (vertebral body tethering for motion-preserving scoliosis treatment), Virage OCT (occipitocervicothoracic fixation), MaxAn (anterior cervical plate), FlareHawk (interbody fusion), LineSider (posterior fixation), and PrimaGen Advanced (allograft biologic). Several of these products carry PMA-class FDA approvals, reflecting substantial regulatory investment.

The business operates a B2B model selling spine implants and instrumentation to hospitals, ambulatory surgery centers, and spine surgeons in the United States. Revenue mechanics are anchored in surgical implant sales, with surgeon relationships and hospital vendor agreements driving recurring volume. The company complements its product business with structured surgeon education programs, tradeshow participation, and patient-facing educational content, but specific pricing models and customer concentration data are not disclosed in source material.

Short descriptiontext

Highridge Medical (formerly LDR Holding) is a spine-focused medical device company based in Austin, Texas, that develops and commercializes cervical, thoracolumbar, and biologic implant systems used by hospitals and spine surgeons across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
spinal implants, spine surgery devices, cervical disc replacement, interbody fusion systems, spinal fixation systems
Industry1 code
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Spinal Implants
Social media profiles1 record
Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1Mobi-C
Description

Cervical Disc product

highridgemedical.com
+9 more records
Core offering1 text field

Designs, develops, manufactures, and commercializes surgical implants and instrumentation for spinal surgery. The portfolio spans cervical disc replacement (motion-preserving arthroplasty), spinal fixation systems, interbody fusion devices using porous titanium technology with VerteBridge plating, non-fusion vertebral body tethering for scoliosis treatment, and biologic allografts for spine procedures.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Highridge Medical offers a comprehensive spine portfolio consisting of cervical solutions, thoracolumbar solutions, enabling technologies, and biologic solutions. The product portfolio includes cervical disc replacement devices (Mobi-C, ROI-C), spinal fixation systems (Vital, Virage, LineSider), interbody fusion systems (TrellOss-L, TrellOss-C, FlareHawk), anterior cervical plates (MaxAn), vertebral body tethering (The Tether), and biologic materials (PrimaGen Advanced allograft). These products serve various spinal surgery needs from motion-preserving disc replacement to deformity correction and fusion procedures.

Product and service5 records
1Mobi-C Cervical Disc
CategoryCervical Spine Implants
Description

A motion-preserving cervical disc replacement implant designed for patients suffering from cervical degenerative disc disease, intended for spine surgeons performing cervical disc arthroplasty procedures.

2Spinal Fixation Systems
CategorySpinal Fixation
Description

Pedicle screw and rod-based fixation systems used by spine surgeons to stabilize the spine during fusion procedures.

3Interbody Fusion Systems
CategoryInterbody Fusion Devices
Description

Interbody cages featuring porous titanium technology and the proprietary VerteBridge plating system, used by spine surgeons performing cervical and lumbar interbody fusion procedures.

4Vertebral Body Tethering System
CategoryNon-Fusion Scoliosis Treatment
Description

A non-fusion scoliosis treatment system that uses vertebral body tethering to correct spinal curvature while preserving motion, intended for pediatric and adolescent patients with idiopathic scoliosis.

5Spine Biologic Allografts
CategorySpine Biologics
Description

Biologic allograft products used by spine surgeons to facilitate bone growth and fusion in spinal surgery procedures.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

SeaSpine is a spine-only medical technology company focused on thoracolumbar and cervical fusion, orthobiologics, and instrumentation — comparable in scope and channel to Highridge's thoracolumbar and biologic offerings.

TypeDirect peer
Description

ATEC is a focused spine pure-play developing and commercializing surgical solutions for the treatment of spinal disorders, with a product strategy and surgeon-driven sales motion similar to Highridge's.

TypeEmerging player
Description

Centinel Spine is a focused motion-preservation company (prodisc cervical and lumbar disc systems). It is a direct competitor in the cervical disc category where Mobi-C is a flagship Highridge product.

TypeBroad incumbent
Description

Zimmer Biomet is a global orthopedic and spine incumbent. Its prior ownership of LDR Holding's spine assets and continuing presence in cervical and thoracolumbar markets makes it a relevant incumbent comparable, particularly for motion-preservation and cervical procedures.

TypeDirect peer
Description

NuVasive is a spine pure-play with cervical and thoracolumbar solutions, minimally invasive spine surgery, and enabling technologies. Its product breadth and surgeon-driven commercial model closely parallel Highridge's approach.

TypeBroad incumbent
Description

Medtronic's Spine & Biologics business is one of the largest spine implant franchises globally, offering cervical discs, interbody fusion, and fixation systems that directly overlap with Highridge's portfolio categories.

TypeDirect peer
Description

Orthofix is a spine and orthopedics company with cervical, thoracolumbar, and biologic spine offerings. Its spine segment competes in similar procedural categories and hospital channels as Highridge.

TypeEmerging player
Description

SI-BONE is a spine-focused medical device company addressing the sacroiliac joint segment. While narrower in scope, it represents a similar small-cap, focused spine pure-play model targeting specialized procedural niches.

TypeBroad incumbent
Description

Stryker operates a major spine division alongside orthopedics, MedSurg, and neurotechnology. As a broad incumbent with overlapping cervical/thoracolumbar implant offerings, it competes for the same hospital and surgeon accounts as Highridge.

TypeDirect peer
Description

Globus Medical is a leading spine-focused medical device company offering cervical and thoracolumbar fusion, motion preservation, and enabling technologies — directly comparable to Highridge's comprehensive spine portfolio across fusion, disc replacement, and biologics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LDR Holding

Spinal Implantsldr.com

Highridge Medical (formerly LDR Holding) is a spine-focused medical device company based in Austin, Texas, that develops and commercializes cervical, thoracolumbar, and biologic implant systems used by hospitals and spine surgeons across the United States.

What LDR Holding does

LDR Holding, founded in 2004 and headquartered in Austin, Texas, was a medical device company that developed and commercialized systems and instrumentation used in spine treatments and surgeries. Following its 2016 acquisition by Zimmer Biomet and subsequent 2023 divestiture to Linden Capital Partners, the business was rebranded as Highridge Medical and operates as a privately held spine-focused medical device company.

The company maintains a comprehensive spine implant portfolio organized across four categories: cervical solutions, thoracolumbar solutions, enabling technologies, and biologic solutions. Flagship products include Mobi-C (a cervical disc replacement device), ROI-C (cervical disc with integrated plating), Vital (deformity spinal fixation), TrellOss-L and TrellOss-C (porous titanium interbody fusion systems), The Tether (vertebral body tethering for motion-preserving scoliosis treatment), Virage OCT (occipitocervicothoracic fixation), MaxAn (anterior cervical plate), FlareHawk (interbody fusion), LineSider (posterior fixation), and PrimaGen Advanced (allograft biologic). Several of these products carry PMA-class FDA approvals, reflecting substantial regulatory investment.

The business operates a B2B model selling spine implants and instrumentation to hospitals, ambulatory surgery centers, and spine surgeons in the United States. Revenue mechanics are anchored in surgical implant sales, with surgeon relationships and hospital vendor agreements driving recurring volume. The company complements its product business with structured surgeon education programs, tradeshow participation, and patient-facing educational content, but specific pricing models and customer concentration data are not disclosed in source material.

LDR Holding firmographics

Firmographics
Name
LDR Holding
Legal name
Highridge Medical
Website
https://ldr.com
Company type
Private
Founded year
1927
Operating status
Operating
Headcount range
1–10 employees
Short description
Highridge Medical (formerly LDR Holding) is a spine-focused medical device company based in Austin, Texas, that develops and commercializes cervical, thoracolumbar, and biologic implant systems used by hospitals and spine surgeons across the United States.
Ownership category
akta.pro rank

LDR Holding industry classification

Industry
Product category
Spinal Implants
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Spinal implants
  • Spine surgery devices
  • Cervical disc replacement
  • Interbody fusion systems
  • Spinal fixation systems

Where LDR Holding is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

LDR Holding business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

LDR Holding product offering

Product offering

Core offering

Designs, develops, manufactures, and commercializes surgical implants and instrumentation for spinal surgery. The portfolio spans cervical disc replacement (motion-preserving arthroplasty), spinal fixation systems, interbody fusion devices using porous titanium technology with VerteBridge plating, non-fusion vertebral body tethering for scoliosis treatment, and biologic allografts for spine procedures.

Product overview

Highridge Medical offers a comprehensive spine portfolio consisting of cervical solutions, thoracolumbar solutions, enabling technologies, and biologic solutions. The product portfolio includes cervical disc replacement devices (Mobi-C, ROI-C), spinal fixation systems (Vital, Virage, LineSider), interbody fusion systems (TrellOss-L, TrellOss-C, FlareHawk), anterior cervical plates (MaxAn), vertebral body tethering (The Tether), and biologic materials (PrimaGen Advanced allograft). These products serve various spinal surgery needs from motion-preserving disc replacement to deformity correction and fusion procedures.

Differentiator

Problem solved

Functional benefit

Brands

  • Mobi-C: Cervical Disc product
  • Vital
  • TrellOss
  • The Tether
  • ROI-C
  • Virage
  • MaxAn
  • PrimaGen Advanced
  • FlareHawk
  • LineSider

Products and services

  • Mobi-C Cervical Disc A motion-preserving cervical disc replacement implant designed for patients suffering from cervical degenerative disc disease, intended for spine surgeons performing cervical disc arthroplasty procedures.
  • Spinal Fixation Systems Pedicle screw and rod-based fixation systems used by spine surgeons to stabilize the spine during fusion procedures.
  • Interbody Fusion Systems Interbody cages featuring porous titanium technology and the proprietary VerteBridge plating system, used by spine surgeons performing cervical and lumbar interbody fusion procedures.
  • Vertebral Body Tethering System A non-fusion scoliosis treatment system that uses vertebral body tethering to correct spinal curvature while preserving motion, intended for pediatric and adolescent patients with idiopathic scoliosis.
  • Spine Biologic Allografts Biologic allograft products used by spine surgeons to facilitate bone growth and fusion in spinal surgery procedures.

Companies that use LDR Holding

Customer profile

Ideal customer profiles1 record

LDR Holding technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

LDR Holding partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

LDR Holding competitors and assessment

Company assessment

Direct peers

  • SeaSpine: SeaSpine is a spine-only medical technology company focused on thoracolumbar and cervical fusion, orthobiologics, and instrumentation — comparable in scope and channel to Highridge's thoracolumbar and biologic offerings.
  • Alphatec Holdings (ATEC): ATEC is a focused spine pure-play developing and commercializing surgical solutions for the treatment of spinal disorders, with a product strategy and surgeon-driven sales motion similar to Highridge's.
  • NuVasive: NuVasive is a spine pure-play with cervical and thoracolumbar solutions, minimally invasive spine surgery, and enabling technologies. Its product breadth and surgeon-driven commercial model closely parallel Highridge's approach.
  • Orthofix Medical: Orthofix is a spine and orthopedics company with cervical, thoracolumbar, and biologic spine offerings. Its spine segment competes in similar procedural categories and hospital channels as Highridge.
  • Globus Medical: Globus Medical is a leading spine-focused medical device company offering cervical and thoracolumbar fusion, motion preservation, and enabling technologies — directly comparable to Highridge's comprehensive spine portfolio across fusion, disc replacement, and biologics.

Emerging players

  • Centinel Spine: Centinel Spine is a focused motion-preservation company (prodisc cervical and lumbar disc systems). It is a direct competitor in the cervical disc category where Mobi-C is a flagship Highridge product.
  • SI-BONE: SI-BONE is a spine-focused medical device company addressing the sacroiliac joint segment. While narrower in scope, it represents a similar small-cap, focused spine pure-play model targeting specialized procedural niches.

Broad incumbents

  • Zimmer Biomet: Zimmer Biomet is a global orthopedic and spine incumbent. Its prior ownership of LDR Holding's spine assets and continuing presence in cervical and thoracolumbar markets makes it a relevant incumbent comparable, particularly for motion-preservation and cervical procedures.
  • Medtronic (Spine): Medtronic's Spine & Biologics business is one of the largest spine implant franchises globally, offering cervical discs, interbody fusion, and fixation systems that directly overlap with Highridge's portfolio categories.
  • Stryker (Spine): Stryker operates a major spine division alongside orthopedics, MedSurg, and neurotechnology. As a broad incumbent with overlapping cervical/thoracolumbar implant offerings, it competes for the same hospital and surgeon accounts as Highridge.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

LDR Holding social profiles

Digital presence

LDR Holding financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LDR Holding leadership team

Management profile

Number of profiles

Profiles4 records

LDR Holding funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LDR Holding M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LDR Holding

What does LDR Holding do?

Designs, develops, manufactures, and commercializes surgical implants and instrumentation for spinal surgery. The portfolio spans cervical disc replacement (motion-preserving arthroplasty), spinal fixation systems, interbody fusion devices using porous titanium technology with VerteBridge plating, non-fusion vertebral body tethering for scoliosis treatment, and biologic allografts for spine procedures.

Is LDR Holding a public or private company?

LDR Holding is a private company. It is classified as unknown and is currently operating.

When was LDR Holding founded?

LDR Holding was founded in 1927. It employs 1 to 10 people.

Where is LDR Holding based?

LDR Holding is headquartered in Austin, United States, in the North America region.

Who are LDR Holding's main competitors?

Direct peers on record are SeaSpine, Alphatec Holdings (ATEC), NuVasive, Orthofix Medical and Globus Medical. Emerging players are Centinel Spine and SI-BONE. Broad incumbents are Zimmer Biomet, Medtronic (Spine) and Stryker (Spine).

Does LDR Holding have an API?

No public API is recorded for LDR Holding.

What industry is LDR Holding in?

LDR Holding's product category is Spinal Implants. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous). Its NAICS code is 339112 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireZimmer Biomet Reports Third Quarter 2016 Financial ResultsZimmer Biomet Holdings, Inc. reported third quarter 2016 financial results with net sales of $1.83 billion, a 4.0% increase over the prior year period, and adjusted constant currency revenue growth of 3.5%. Diluted earnings per share were $0.78, representing a 609.1% increase year-over-year, while adjusted diluted EPS reached $1.79, up 9.1%. During the quarter, the company completed three strategic acquisitions—LDR Holding Corporation, CD Diagnostics, and Medtech SA—to expand its musculoskeletal and robotics offerings.PR NewswireZimmer Biomet Completes Tender Offer for Outstanding Shares of LDR Holding CorporationZimmer Biomet Holdings, Inc. announced the successful completion of its tender offer to acquire all outstanding shares of LDR Holding Corporation for $37.00 per share in cash, with the offer expiring at midnight on July 13, 2016. Approximately 82.7% of LDR shares were validly tendered (plus 6.2% through guaranteed delivery procedures), satisfying all conditions for the acquisition to proceed. Zimmer Biomet expects to complete the merger later that day, making LDR an indirect wholly owned subsidiary and positioning the combined entity as a leader in the $10 billion global spine market.PR NewswireZimmer Biomet Announces Early Termination of HSR Waiting PeriodZimmer Biomet Holdings, Inc. announced the early termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period for its tender offer to acquire LDR Holding Corporation for $37.00 per share in cash. The early termination satisfies one of the conditions to the offer, which is scheduled to expire at midnight on July 13, 2016, subject to the tender of a majority of LDR's outstanding shares and other customary closing conditions. Completion of the acquisition remains contingent on shareholder participation and standard regulatory requirements.PR NewswireHealthcare Sector Stocks Technical Coverage -- Aetna, Anthem, LDR Holding, and NeovascStock-Callers.com initiated technical coverage on four healthcare sector stocks — Aetna Inc., Anthem Inc., LDR Holding Corporation, and Neovasc Inc. — on June 21, 2016, providing stock price movements, trading volumes, and technical metrics including PE ratios, moving averages, and RSI values for each company. Aetna and LDR Holding posted gains of 1.02% and 0.08% respectively, while Anthem declined 0.96% and Neovasc fell 23.53% on the session.PR NewswireLDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.Faruqi & Faruqi, LLP announced an investigation into the Board of Directors of LDR Holding Corporation regarding its proposed $1.0 billion acquisition by Zimmer Biomet Holdings. The law firm alleges potential breaches of fiduciary duty due to the offer price of $37.00 per share, which is below analyst targets and the company's recent trading high. The investigation aims to determine if the transaction undervalues the company to the detriment of shareholders.MedCity NewsLDR fights insurance companies for reimbursement of spinal disc implantLDR's Mobi-C cervical disc implant faces patchy insurance reimbursement, with only 50 million of 230 million U.S. insured covered for two-level replacement. Zimmer Biomet agreed to acquire LDR for $1 billion to expand payer access. LDR expects coverage expansion over five years, pending evidence and Medtronic's pending approval.MedCity NewsAustin frets proposed Zimmer Biomet takeover of LDR HoldingsLDR Holdings, an Austin spine device maker, proposed a sale to Zimmer Biomet for about $1 billion, raising local concerns after Zimmer previously bought Austin firms and closed, costing over 500 jobs. Zimmer's president said LDR co-founders would remain in key roles and the deal could close in Q3 2016.PR NewswireINVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRHLaw firm Levi & Korsinsky, LLP announced an investigation into the fairness of Zimmer Biomet Holdings, Inc.'s acquisition of LDR Holding Corporation, which was completed for $37.00 per share in cash. The firm is seeking to determine whether LDR Holding shareholders received adequate compensation in the transaction. Shareholders who purchased LDRH stock prior to June 7, 2016, are being notified of their potential rights related to the matter.PR NewswireLDR Holding Corp. Acquisition May Not Be in the Best Interests of LDRH ShareholdersWeissLaw LLP announced on June 9, 2016, that it is investigating possible breaches of fiduciary duty by LDR Holding Corp.'s Board of Directors in connection with Zimmer Biomet Holdings Inc.'s proposed acquisition of the company for approximately $1 billion, or $37.00 per share in cash. The law firm cited that at least one analyst set a target price of $40.00 per share, the company reported Q1 2016 revenues of $42.4 million (up 8.4% year-over-year), and the offer price is significantly below LDRH's 52-week high of $47.12. WeissLaw is investigating whether the board acted to maximize shareholder value prior to entering into the definitive agreement.